Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells

Allan R. Shepard, Nasreen Jacobson, John H. Fingert, Edwin M. Stone, Val C. Sheffield, Abbot F. Clark

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

PURPOSE. To characterize the glucocorticoid responsiveness of the glaucoma gene MYOC (myocilin/TIGR) in cultured human trabecular meshwork (TM) cells. METHODS. MYOC expression in two independently derived human TM cell lines was quantified by Western immunoblot analysis of protein levels and quantitative PCR analysis of mRNA levels. Promoter activity was measured indirectly with the luciferase reporter gene in a dual luciferase reporter assay. RESULTS. Application of the synthetic glucocorticoid dexamethasone (Dex) to cultured TM cells at 100 nM resulted in a delayed (8-16 hours) induction of myocilin. The concentration dependence (median effective concentration [EC 50], ∼ 10 nM) and reversal by the glucocorticoid antagonist, RU486, implicates the glucocorticoid receptor (GR). In an interesting observation, RU486 alone acted as a partial agonist to MYOC expression. Treatment of TM cells with the protein synthesis inhibitor cycloheximide abolished the Dex induction, suggesting an indirect effect of the GR on MYOC expression. In addition, the RNA synthesis inhibitor actinomycin D also blocked Dex induction, indicating that the Dex effect was due to increased MYOC transcription. Analysis of up to 2700 nucleotides (nt) of the MYOC gene 5′-flanking region in luciferase reporter constructs showed no Dex induction, despite the presence of multiple putative glucocorticoid response element (GRE)-like half-sites in the MYOC promoter and the presence of an intact cellular GR-mediated signaling system. CONCLUSIONS. MYOC is a delayed secondary glucocorticoid-responsive-gene. Characterization of the transcription factors that mediate the secondary response will shed new light on the pathophysiology of steroid-induced ocular hypertension and glaucoma.

Original languageEnglish
Pages (from-to)3173-3181
Number of pages9
JournalInvestigative Ophthalmology and Visual Science
Volume42
Issue number13
StatePublished - 1 Dec 2001

Fingerprint

Trabecular Meshwork
Glucocorticoids
Dexamethasone
Glucocorticoid Receptors
Luciferases
Glaucoma
Genes
Nucleic Acid Synthesis Inhibitors
trabecular meshwork-induced glucocorticoid response protein
Ocular Hypertension
Protein Synthesis Inhibitors
5' Flanking Region
Response Elements
Dactinomycin
Cycloheximide
Reporter Genes
Transcription Factors
Nucleotides
Western Blotting
Steroids

Cite this

Shepard, A. R., Jacobson, N., Fingert, J. H., Stone, E. M., Sheffield, V. C., & Clark, A. F. (2001). Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Investigative Ophthalmology and Visual Science, 42(13), 3173-3181.
Shepard, Allan R. ; Jacobson, Nasreen ; Fingert, John H. ; Stone, Edwin M. ; Sheffield, Val C. ; Clark, Abbot F. / Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. In: Investigative Ophthalmology and Visual Science. 2001 ; Vol. 42, No. 13. pp. 3173-3181.
@article{ab47c2d3ce0d4050bb6cbd544051a775,
title = "Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells",
abstract = "PURPOSE. To characterize the glucocorticoid responsiveness of the glaucoma gene MYOC (myocilin/TIGR) in cultured human trabecular meshwork (TM) cells. METHODS. MYOC expression in two independently derived human TM cell lines was quantified by Western immunoblot analysis of protein levels and quantitative PCR analysis of mRNA levels. Promoter activity was measured indirectly with the luciferase reporter gene in a dual luciferase reporter assay. RESULTS. Application of the synthetic glucocorticoid dexamethasone (Dex) to cultured TM cells at 100 nM resulted in a delayed (8-16 hours) induction of myocilin. The concentration dependence (median effective concentration [EC 50], ∼ 10 nM) and reversal by the glucocorticoid antagonist, RU486, implicates the glucocorticoid receptor (GR). In an interesting observation, RU486 alone acted as a partial agonist to MYOC expression. Treatment of TM cells with the protein synthesis inhibitor cycloheximide abolished the Dex induction, suggesting an indirect effect of the GR on MYOC expression. In addition, the RNA synthesis inhibitor actinomycin D also blocked Dex induction, indicating that the Dex effect was due to increased MYOC transcription. Analysis of up to 2700 nucleotides (nt) of the MYOC gene 5′-flanking region in luciferase reporter constructs showed no Dex induction, despite the presence of multiple putative glucocorticoid response element (GRE)-like half-sites in the MYOC promoter and the presence of an intact cellular GR-mediated signaling system. CONCLUSIONS. MYOC is a delayed secondary glucocorticoid-responsive-gene. Characterization of the transcription factors that mediate the secondary response will shed new light on the pathophysiology of steroid-induced ocular hypertension and glaucoma.",
author = "Shepard, {Allan R.} and Nasreen Jacobson and Fingert, {John H.} and Stone, {Edwin M.} and Sheffield, {Val C.} and Clark, {Abbot F.}",
year = "2001",
month = "12",
day = "1",
language = "English",
volume = "42",
pages = "3173--3181",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "13",

}

Shepard, AR, Jacobson, N, Fingert, JH, Stone, EM, Sheffield, VC & Clark, AF 2001, 'Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells', Investigative Ophthalmology and Visual Science, vol. 42, no. 13, pp. 3173-3181.

Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. / Shepard, Allan R.; Jacobson, Nasreen; Fingert, John H.; Stone, Edwin M.; Sheffield, Val C.; Clark, Abbot F.

In: Investigative Ophthalmology and Visual Science, Vol. 42, No. 13, 01.12.2001, p. 3173-3181.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells

AU - Shepard, Allan R.

AU - Jacobson, Nasreen

AU - Fingert, John H.

AU - Stone, Edwin M.

AU - Sheffield, Val C.

AU - Clark, Abbot F.

PY - 2001/12/1

Y1 - 2001/12/1

N2 - PURPOSE. To characterize the glucocorticoid responsiveness of the glaucoma gene MYOC (myocilin/TIGR) in cultured human trabecular meshwork (TM) cells. METHODS. MYOC expression in two independently derived human TM cell lines was quantified by Western immunoblot analysis of protein levels and quantitative PCR analysis of mRNA levels. Promoter activity was measured indirectly with the luciferase reporter gene in a dual luciferase reporter assay. RESULTS. Application of the synthetic glucocorticoid dexamethasone (Dex) to cultured TM cells at 100 nM resulted in a delayed (8-16 hours) induction of myocilin. The concentration dependence (median effective concentration [EC 50], ∼ 10 nM) and reversal by the glucocorticoid antagonist, RU486, implicates the glucocorticoid receptor (GR). In an interesting observation, RU486 alone acted as a partial agonist to MYOC expression. Treatment of TM cells with the protein synthesis inhibitor cycloheximide abolished the Dex induction, suggesting an indirect effect of the GR on MYOC expression. In addition, the RNA synthesis inhibitor actinomycin D also blocked Dex induction, indicating that the Dex effect was due to increased MYOC transcription. Analysis of up to 2700 nucleotides (nt) of the MYOC gene 5′-flanking region in luciferase reporter constructs showed no Dex induction, despite the presence of multiple putative glucocorticoid response element (GRE)-like half-sites in the MYOC promoter and the presence of an intact cellular GR-mediated signaling system. CONCLUSIONS. MYOC is a delayed secondary glucocorticoid-responsive-gene. Characterization of the transcription factors that mediate the secondary response will shed new light on the pathophysiology of steroid-induced ocular hypertension and glaucoma.

AB - PURPOSE. To characterize the glucocorticoid responsiveness of the glaucoma gene MYOC (myocilin/TIGR) in cultured human trabecular meshwork (TM) cells. METHODS. MYOC expression in two independently derived human TM cell lines was quantified by Western immunoblot analysis of protein levels and quantitative PCR analysis of mRNA levels. Promoter activity was measured indirectly with the luciferase reporter gene in a dual luciferase reporter assay. RESULTS. Application of the synthetic glucocorticoid dexamethasone (Dex) to cultured TM cells at 100 nM resulted in a delayed (8-16 hours) induction of myocilin. The concentration dependence (median effective concentration [EC 50], ∼ 10 nM) and reversal by the glucocorticoid antagonist, RU486, implicates the glucocorticoid receptor (GR). In an interesting observation, RU486 alone acted as a partial agonist to MYOC expression. Treatment of TM cells with the protein synthesis inhibitor cycloheximide abolished the Dex induction, suggesting an indirect effect of the GR on MYOC expression. In addition, the RNA synthesis inhibitor actinomycin D also blocked Dex induction, indicating that the Dex effect was due to increased MYOC transcription. Analysis of up to 2700 nucleotides (nt) of the MYOC gene 5′-flanking region in luciferase reporter constructs showed no Dex induction, despite the presence of multiple putative glucocorticoid response element (GRE)-like half-sites in the MYOC promoter and the presence of an intact cellular GR-mediated signaling system. CONCLUSIONS. MYOC is a delayed secondary glucocorticoid-responsive-gene. Characterization of the transcription factors that mediate the secondary response will shed new light on the pathophysiology of steroid-induced ocular hypertension and glaucoma.

UR - http://www.scopus.com/inward/record.url?scp=0035651036&partnerID=8YFLogxK

M3 - Article

C2 - 11726619

AN - SCOPUS:0035651036

VL - 42

SP - 3173

EP - 3181

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 13

ER -